Estimates of the annual number and cost of new HIV infections among women attributable to trichomoniasis in the United States

Sexually Transmitted Diseases

Volumn 31, Issue 9, 2004, Pages 547-551

  Chesson, Harrell W ^a   Blandford, John M ^a   Pinkerton, Steven D ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION SENSITIVITY; MATHEMATICAL MODEL; PREVENTIVE MEDICINE; PROBABILITY; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; TRICHOMONIASIS; UNITED STATES; VIRUS INFECTIVITY; VIRUS TRANSMISSION;

DISEASE SUSCEPTIBILITY; DISEASE TRANSMISSION, HORIZONTAL; FEMALE; HEALTH CARE COSTS; HIV INFECTIONS; HUMANS; MALE; MODELS, STATISTICAL; PROBABILITY; TRICHOMONAS VAGINITIS; UNITED STATES; WOMEN'S HEALTH;

EID: 4344638187     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000137900.63660.98     Document Type: Article

References (35)

1. Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992; 19:61-77.
2. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3-17.
3. Centers for Disease Control and Prevention. HIV prevention through early detection and treatment of other sexually transmitted diseases - United States. MMWR Recomm Rep 1998; 47(RR-12):1-24.
4. Cohen MS. Sexually transmitted diseases enhance HIV transmission: No longer a hypothesis. Lancet 1998; 351(suppl 3):5-7.
5. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1. Lancet 1997; 349: 1868-1873.
6. Jackson DJ, Rakwar JP, Bwayo JJ, et al. Urethral Trichomonas vaginalis infection and HIV-1 transmission. Lancet 1997; 350:1076.
7. Sorvillo F, Kerndt P. Trichomonas vaginalis and amplification of HIV-1 transmission. Lancet 1998; 351:213-214.
8. Hook EW III. Trichomonas vaginalis - No longer a minor STD. Sex Transm Dis 1999; 26:388-389.
9. Sorvillo F, Smith L, Kerndt P, et al. Trichomonas vaginalis, HIV, and African-Americans. Emerg Infect Dis 2001; 7:927-932.
10. Schwebke JR. Update of trichomoniasis. Sex Transm Infect 2002; 78:378-379.
11. Division of STD Prevention. Trichomoniasis. Atlanta: Division of STD Prevention, Centers for Disease Control and Prevention, 2002.
12. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004; 36:6-10.
13. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study. AIDS 1993; 7:95-102.
14. Ghys PD, Diallo MO, Ettiegne-Traore V, et al. Genital ulcers associated with human immunodeficiency virus-related immunosuppression in female sex workers in Abidjan, Ivory Coast. J Infect Dis 1995; 172:1371-1374.
15. ter Meulen J, Mgaya HN, Chang-Claude J, et al. Risk factors for HIV infection in gynaecological inpatients in Dar es Salaam, Tanzania, 1988-1990. East Afr Med J 1992; 69:688-692.
16. Laga M, Alary M, Nzila N, et al. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet 1994; 344:246-48.
17. Chesson HW, Pinkerton SD. Sexually transmitted diseases and the increased risk for HIV transmission: Implications for cost-effectiveness analyses of sexually transmitted disease prevention interventions. J Acquir Immune Defic Syndr 2000; 24:48-56.
18. Dow WH, Philipson T. An empirical examination of the implications of assortative matching on the incidence of HIV. J Health Econ 1996; 15:735-749.
19. Rosenberg PS. Scope of the AIDS epidemic in the United States. Science 1995; 270:1372-1375.
20. Chesson HW, Pinkerton SD, Voigt R, et al. HIV infections and associated costs attributable to syphilis coinfection among African Americans. Am J Public Health 2003; 93:943-948.
21. Krieger JN, Alderete JF. Trichomonas vaginalis and trichomoniasis. In: Holmes KK, Sparling PF, Mardh P, et al., eds. Sexually Transmitted Diseases. New York: McGraw-Hill, 1999:587-604.
22. Mastro TD, de Vincenzi I. Probabilities of sexual HIV-1 transmission. AIDS 1996; 10(suppl A):S75-82.
23. Royce RA, Sena A, Cates W Jr, et al. Sexual transmission of HIV. N Engl J Med 1997; 336:1072-1078.
24. Rehle TM, Saidel TJ, Hassig SE, et al. AVERT: A user-friendly model to estimate the impact of HIV/sexually transmitted disease prevention interventions on HIV transmission. AIDS 1998; 12(suppl 2): S27-S35.
25. Bowden FJ, Garnett GP. Trichomonas vaginalis epidemiology: Parameterising and analysing a model of treatment interventions. Sex Transm Infect 2000; 76:248-256.
26. Laumann EO, Gagnon JH, Michael RT, et al. The Social Organization of Sexuality. Chicago: The University of Chicago Press, 1994.
27. Cotch MF, Pastorek JG, Nugent RP, et al. Demographic and behavioral predictors of Trichomonas vaginalis infection among pregnant women. Obstet Gynecol 1991; 78:1087-1092.
28. Holtgrave DR, Pinkerton SD. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16:54-62.
29. Doubilet P, Begg CB, Weinstein MC, et al. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making 1985; 5:157-177.
30. Division of HIV Prevention. A Glance at the HIV Epidemic. Atlanta: Centers for Disease Control and Prevention, 2001.
31. Rothenberg RB, Wasserheit JN, St. Louis ME, et al. The effect of treating sexually transmitted diseases on the transmission of HIV in dually infected persons: A clinic-based estimate. Sex Transm Dis 2000; 27:411-416.
32. Hayes RJ, Schulz KF, Plummer FA. The cofactor effect of genital ulcers on the per-exposure risk of HIV transmission in sub-Saharan Africa. J Trop Med Hyg 1995; 98:1-8.
33. Chesson HW, Pinkerton SD, Irwin KL, et al. New HIV cases attributable to syphilis in the USA: Estimates from a simplified transmission model. AIDS 1999; 13:1387-1396.
34. Pinkerton SD, Abramson PR. Evaluating the risks: A Bemoulli process model of HIV infection and risk reduction. Eval Rev 1993; 18:504-528.
35. Holtgrave DR, Leviton LC, Wagstaff DA, et al. Cumulative probability of HIV infection: A summary risk measure for HIV prevention intervention studies. AIDS Behav 1997; 1:169-172.